HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Szwergold, B. S. Articles by Beisswenger, P. J. Search for Related Content PubMed PubMed Citation Articles by Szwergold, B. S. Articles by Beisswenger, P. J. Social Bookmarking                What's this?

Human Fructosamine-3-Kinase

Purification, Sequencing, Substrate Specificity, and Evidence of Activity In Vivo

Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire

Nonenzymatic glycation appears to be an important factor in the pathogenesis of diabetic complications. Key early intermediates in this process are fructosamines, such as protein-bound fructoselysines. In this report, we describe the purification and characterization of a mammalian fructosamine-3-kinase (FN3K), which phosphorylates fructoselysine (FL) residues on glycated proteins, to FL-3-phosphate (FL3P). This phosphorylation destablilizes the FL adduct and leads to its spontaneous decomposition, thereby reversing the nonenzymatic glycation process at an early stage. FN3K was purified to homogeneity from human erythrocytes and sequenced by means of electrospray tandem mass spectrometry. The protein thus identified is a 35-kDa monomer that appears to be expressed in all mammalian tissues. It has no significant homology to other known proteins and appears to be encoded by genomic sequences located on human chromosomes 1 and 17. The lability of FL3P, the high affinity of FN3K for FL, and the wide distribution of FN3K suggest that the function of this enzyme is deglycation of nonenzymatically glycated proteins. Because the condensation of glucose and lysine residues is an ubiquitous and unavoidable process in homeothermic organisms, a deglycation system mediated by FN3K may be an important factor in protecting cells from the deleterious effects of nonenzymatic glycation. Our sequence data of FN3K are in excellent agreement with a recent report on this enzyme by Delpierre et al. (Diabetes 49:1627–1634, 2000).

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. M. Cohen, H. Snieder, C. J. Lindsell, H. Beyan, M. I. Hawa, S. Blinko, R. Edwards, T. D. Spector, and R. D. G. Leslie Evidence for Independent Heritability of the Glycation Gap (Glycosylation Gap) Fraction of HbA1c in Nondiabetic Twins Diabetes Care, August 1, 2006; 29(8): 1739 - 1743. [Abstract] [Full Text] [PDF]

				J. Fortpied, P. Maliekal, D. Vertommen, and E. Van Schaftingen Magnesium-dependent Phosphatase-1 Is a Protein-Fructosamine-6-phosphatase Potentially Involved in Glycation Repair J. Biol. Chem., July 7, 2006; 281(27): 18378 - 18385. [Abstract] [Full Text] [PDF]

				H. Sakiyama, M. Takahashi, T. Yamamoto, T. Teshima, S. H. Lee, Y. Miyamoto, Y. Misonou, and N. Taniguchi The Internalization and Metabolism of 3-Deoxyglucosone in Human Umbilical Vein Endothelial Cells J. Biochem., February 1, 2006; 139(2): 245 - 253. [Abstract] [Full Text] [PDF]

				P. J. Beisswenger, K. S. Drummond, R. G. Nelson, S. K. Howell, B. S. Szwergold, and M. Mauer Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress Diabetes, November 1, 2005; 54(11): 3274 - 3281. [Abstract] [Full Text] [PDF]

				N. Ahmed, R. Babaei-Jadidi, S. K. Howell, P. J. Thornalley, and P. J. Beisswenger Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes Diabetes Care, October 1, 2005; 28(10): 2465 - 2471. [Abstract] [Full Text] [PDF]

				J. Delplanque, G. Delpierre, F. R. Opperdoes, and E. Van Schaftingen Tissue Distribution and Evolution of Fructosamine 3-Kinase and Fructosamine 3-Kinase-related Protein J. Biol. Chem., November 5, 2004; 279(45): 46606 - 46613. [Abstract] [Full Text] [PDF]

				S.-i. Akazawa, T. Karino, N. Yoshida, T. Katsuragi, and Y. Tani Functional Analysis of Fructosyl-Amino Acid Oxidases of Aspergillus oryzae Appl. Envir. Microbiol., October 1, 2004; 70(10): 5882 - 5890. [Abstract] [Full Text] [PDF]

				G. Delpierrre, D. Vertommen, D. Communi, M. H. Rider, and E. Van Schaftingen Identification of Fructosamine Residues Deglycated by Fructosamine-3-kinase in Human Hemoglobin J. Biol. Chem., June 25, 2004; 279(26): 27613 - 27620. [Abstract] [Full Text] [PDF]

				F. Collard, G. Delpierre, V. Stroobant, G. Matthijs, and E. Van Schaftingen A Mammalian Protein Homologous to Fructosamine-3-Kinase Is a Ketosamine-3-Kinase Acting on Psicosamines and Ribulosamines but not on Fructosamines Diabetes, December 1, 2003; 52(12): 2888 - 2895. [Abstract] [Full Text] [PDF]

				E. Wiame, G. Delpierre, F. Collard, and E. Van Schaftingen Identification of a Pathway for the Utilization of the Amadori Product Fructoselysine in Escherichia coli J. Biol. Chem., November 1, 2002; 277(45): 42523 - 42529. [Abstract] [Full Text] [PDF]